[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"rotator-cuff-injury\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:rotator-cuff-injury":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,49,82,102,135,167,193,217],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":4},"100641423","platelet-rich-plasma-for-partial-rotator-cuff-tears-100641423",false,"NCT07659600","Platelet-Rich Plasma for Partial Rotator Cuff Tears","Performance of Autologous Platelet-rich Plasma Injection for Tendon Regeneration in Partial Supraspinatus Tears","OPTIMISE","Inclusion Criteria:\n\n* Eligible patients are at least 18 years old, and have clinical (VAS pain score ≥4, loss of \\>25% in ROM, positive in at least one clinical test such as Jobe, Neer, Drop arm, Hawins-Kennedy, Patte) and imaging findings compatible with partial supraspinatus tear, within 3 months of diagnosis.\n* Patients may have undergone conservative treatments, including lifestyle modification, oral analgesics, or physical therapy, with the exception of shoulder injections.\n* Must be willing to provide consent.\n\nExclusion Criteria:\n\n* Patients less than 18 years old\n* Patients with other or concomitant rotator cuff or shoulder muscle\u002Ftendon tear(s), complete tears, SLAP tears ≥ grade 2\n* Patients with auto-immune based joint diseases, osteoarthritis (KL grade ≥ 2), adhesive capsulitis, infection, nerve-related conditions, immunocompromised conditions, malignancy, coagulopathy\n* Patients on antiplatelet, anticoagulant, antitumor or immunosuppressive drugs\n* Uncontrolled diabetes, other systemic disorders (hepatitis, rheumatoid arthritis)\n* Pregnancy\n* Shoulder instability\n* Previous shoulder injection or surgery\n* Unwillingness to provide informed consent","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to learn whether platelet-rich plasma (PRP) injection, made from a participant's own blood, can help heal the tendon and improve shoulder symptoms in people with partial tears of the supraspinatus tendon.\n\nThe main questions it aims to answer are:\n\n* Does PRP help the tendon heal?\n* Does PRP improve pain, shoulder movement, daily function, and shoulder magnetic resonance imaging (MRI) findings?\n\nResearchers will compare PRP plus standard of care (physical therapy) to standard of care alone to see if PRP leads to better healing and better clinical results. Researchers will also study if differences in specific biomolecules in PRP are associated with differences in treatment response.\n\nParticipants will:\n\n* receive standard of care treatment, with or without PRP injection depending on the study group\n* have blood collected for PRP preparation\n* have their pain, shoulder movement, and shoulder function assessed\n* undergo shoulder MRI scans\n* be followed over time to measure healing and symptom improvement",[27,28,29],"Partial Supraspinatus Tear","Rotator Cuff Tears (RCTs)","Rotator Cuff Injury",[31,32,33,34,35,36],"Platelet-Rich Plasma","Partial Supraspinatus Tears","Rotator Cuff Tears","Autologous PRP","PRP","Shoulder pain","NOT_YET_RECRUITING","2026-06-15",{"date":40,"type":41},"2026-06-22","ACTUAL",{"date":43,"type":21},"2026-06-01",{"date":45,"type":21},"2029-12-01",{"name":47,"class":48},"Universidade Nova de Lisboa","OTHER",{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":81},"100621914","effect-of-sleeping-posture-guidance-on-sleep-quality-in-patients-with-rotator-cuff-syndrome-100621914","NCT07376811","Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome","Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome Undergoing Physical Therapy: A Randomized Clinical Trial","Inclusion Criteria:\n\n* Clinical and\u002For radiological diagnosis of Rotator Cuff Syndrome (RCS).\n* Presence of shoulder pain for at least 3 months (chronic pain).\n* Patients aged between 18 and 65 years.\n* Patients referred for conservative physical therapy treatment.\n* Ability to understand and answer the assessment questionnaires (PSQI, MSQ, ASES, and VAS).\n* Voluntarily signing the Informed Consent Form (ICF).\n\nExclusion Criteria:\n\n* History of surgical procedures on the affected shoulder.\n* Presence of fractures or recent acute trauma in the shoulder or upper limb.\n* Associated neurological disorders, inflammatory systemic diseases (e.g., Rheumatoid Arthritis), or adhesive capsulitis (frozen shoulder).\n* Previous diagnosis of primary sleep disorders unrelated to pain (e.g., severe obstructive sleep apnea) already under clinical treatment.\n* Recent history of corticosteroid injections in the shoulder (within the last 3 months).","65 Years",{"count":58,"type":21},64,[24],"This study investigates sleep quality in patients with Rotator Cuff Syndrome (RCS) undergoing physical therapy treatment. Existing literature presents a gap regarding longitudinal studies evaluating the impact of physical therapy and different sleeping positions on sleep quality within this specific population. The central hypothesis is that physical therapy, combined with guidance on the best sleeping positions, reduces pain, improves shoulder function, and consequently promotes an improvement in sleep quality for RCS patients over time. The justification for this research lies in the need to better understand the relationship between physical therapy and sleep quality in RCS patients, aiming for the development of more effective and less invasive interventions. Previous studies have demonstrated that chronic pain, a common symptom of RCS, is intrinsically linked to sleep disturbances, which can lead to deleterious effects such as dopamine reduction, alterations in the descending pain modulation system, and central sensitization. Improvements in sleep quality have been observed after surgical procedures such as shoulder arthroscopy and arthroplasty, often associated with improved function and pain reduction. Thus, this study seeks to longitudinally evaluate whether physical therapy is capable of promoting a sustained improvement in sleep quality for patients with RCS",[62,29,63],"Rotator Cuff Syndrome","Sleep Disorder (Disorder)",[65,66,67,68,69,70,71],"rotator cuff syndrome","sleep quality","sleeping position","physical therapy","randomized controlled trial","shoulder pain","rehabilitation","2026-01-25",{"date":74,"type":41},"2026-01-29",{"date":76,"type":21},"2026-03-01",{"date":78,"type":21},"2029-11-01",{"name":80,"class":48},"Federal University of São Paulo",1,{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":22,"phases":90,"briefSummary":91,"conditions":92,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":81},"100593664","pillow-brace-assessment-on-sleep-quality-of-patients-undergoing-arthroscopic-rotator-cuff-surgery-100593664","NCT07009379","Pillow Brace Assessment on Sleep Quality of Patients Undergoing Arthroscopic Rotator Cuff Surgery","PILLOW BRACE","Inclusion Criteria:\n\n* Patient undergoing arthroscopic rotator cuff repair surgery confirmed by clinical diagnosis and preoperative imaging tests.\n* Patient able to understand the instructions for using the brace.\n* Patient able to perform activities of daily living with or without a brace, ensuring proper use of the brace.\n* Patient affiliated with or beneficiary of a social security system\n* French speaking patient, having signed an informed consent form\n\nExclusion Criteria:\n\n* Patient with an uncertain diagnosis\n* Patient undergoing rotator cuff revision surgery.\n* Patient with complex or surgical fractures of the shoulder, humerus, or ribs\n* Patient with multiple fractures, open fractures, or those with pinning\n* Patient who has undergone multiple surgeries in the last 6 months.\n* Patient with shoulder pathologies unrelated to the rotator cuff, such as severe arthritis or capsulitis.\n* Patient on long-term morphine treatment\n* Patient with known allergies to splint materials\n* Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative order\n* Pregnant woman\n* Patient hospitalized without consent\n* Patient already enrolled and participating in another clinical study",{"count":20,"type":21},[24],"Rotator cuff surgery is an increasingly popular procedure in France. It is a common procedure for patients with shoulder tendon injuries, aimed at restoring mobility and reducing pain. Although arthroscopic techniques have improved functional outcomes, managing postoperative pain, particularly at night, and its consequences remains a major challenge.\n\nStudies highlight that postoperative nighttime pain can significantly affect sleep quality, delaying functional recovery and patient satisfaction. However, standard splints used for postoperative immobilization do not offer an optimal solution to this problem, leaving a significant gap in the care of these patients.\n\nGiven this observation, a splint incorporating a support cushion system could meet the specific needs expressed by patients who have undergone rotator cuff surgery, namely improving sleep quality by minimizing nighttime pain. This splint, called the \"Pillow Brace,\" was developed internally at the Jouvenet Clinic. It therefore does not have CE marking.\n\nNevertheless, this study is based on the hypothesis that the use of a \"Pillow Brace\" could significantly improve sleep quality compared to standard splints, thus making a significant contribution to orthopedic medicine, postoperative rehabilitation, and patient quality of life.",[29],"2025-09-26",{"date":95,"type":41},"2025-09-29",{"date":97,"type":21},"2025-10-01",{"date":99,"type":21},"2027-07-31",{"name":101,"class":48},"GCS Ramsay Santé pour l'Enseignement et la Recherche",{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":17,"minAge":110,"maxAge":56,"enrollmentInfo":111,"targetDuration":4,"studyType":22,"phases":113,"briefSummary":114,"conditions":115,"keywords":118,"overallStatus":124,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":81},"100593332","rotator-cuff-tendon-repair-with-fiberlocker-system-patch-augmentation-100593332","NCT07005063","Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation","Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation: A Prospective, Single-Arm, Non-Randomized, Pilot Study","FIBERLOCK","Inclusion Criteria:\n\n1. Subject requires surgical treatment of a full-thickness rotator cuff tear, according to Balgrist standard procedure\n2. Full-thickness tear of the supraspinatus or combined infraspinatus and supraspinatus\n3. The rotator cuff tear is of traumatic origin.\n4. Subject is ≥ 40 years of age \\& ≤ 65 years of age.\n5. Primary rotator cuff repair\n6. Informed Consent signed by the subject\n7. Pre-operative MRI performed\n\nExclusion Criteria:\n\n1. Vulnerable subjects (as defined in ISO 14155)\n2. Subjects who do not have the power of judgement or are unable to fully understand all aspects of the investigation that are relevant to the decision to participate\n3. Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation,\n4. Previous enrolment into the current investigation,\n5. Enrolment of the PI, his\u002Fher family members, employees and other dependent persons,\n6. Inability to follow the procedures of the investigation, or known or suspected non-compliance, e.g. due to language problems, psychological disorders, dementia, drug or alcohol abuse, etc. of the subject\n7. Active smoker\n8. History of claustrophobia that would prevent an MRI of the index shoulder\n9. Presence of an implanted metallic device or other implants that would contraindicate acquisition or inhibit radiologist review of an MRI of the index shoulder\n10. Pregnant or planning to become pregnant during the study period\n11. Breast feeding women\n12. Subject has conditions or circumstances that would interfere with study requirements.\n13. Contraindications and limitations of the MD as described in the IFUs.\n14. Partial rotator cuff tears\n15. History or known allergy or intolerance to polyester\n16. Complete full-thickness subscapularis tears greater than the superior 1\u002F3 of the tendon, with Lafosse grade 3 or greater\n17. Massive rotator cuff tears, tear size equal to or greater than 4 cm in the anterior-posterior dimension or irreparable rotator cuff tear\n18. Limited space or exposure for implant delivery\n19. Structural or pathological condition of the bone or soft tissue that could impair healing.\n20. Intraoperative rotator cuff tear characteristics differ from preoperatively expected characteristics and fulfil one of the abovementioned criteria\n21. Fatty infiltration of the index shoulder rotator cuff muscle \\> Goutallier Score 2\n22. Corticosteroid injection in the operative shoulder within 6 weeks of operation\n23. Subject shows frozen shoulder\u002Fadhesive capsulitis at day of surgery\n24. Cases of moderate to severe osteoarthritis\n25. Patients with inflammatory disease or auto-immune based joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, arthropathy)\n26. Subjects with diabetes type I or II\n27. The subject currently has an acute infection in the area surrounding the surgical site\n28. Evidence of active infection, osteomyelitis, sepsis or distant infection which could spread to the index joint.\n29. Any comorbidity or condition that renders the patient a poor surgical candidate as determined by the Investigator.","40 Years",{"count":112,"type":21},50,[24],"The overall objective of this clinical investigation is to assess the safety and efficacy of full-thickness arthroscopic rotator cuff repairs augmented with the FiberLocker System for the subjects. The primary outcome of the investigation is to assess the safety after full-thickness arthroscopic rotator cuff repairs augmented with the FiberLocker System in terms of postoperative adverse events through the 12-month follow-up. Main secondary outcomes include measures of efficacy and clinical performance evaluated at 6-week, 4.5-month, and 12-month follow-ups including retear rate assessed using MRI and different functional performance scores.",[116,29,117],"Rotator Cuff Tear","Rotator Cuff Rupture",[119,120,121,122,123],"Rotator cuff tear","Rotator cuff repair","Augmentation","Reinforcement","Mechanical augmentation","RECRUITING","2025-07-16",{"date":127,"type":41},"2025-07-17",{"date":129,"type":41},"2025-07-03",{"date":131,"type":21},"2029-06-30",{"name":133,"class":134},"ZuriMED Technologies AG","INDUSTRY",{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":4,"eligibilityCriteria":141,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":4,"enrollmentInfo":142,"targetDuration":4,"studyType":22,"phases":144,"briefSummary":146,"conditions":147,"keywords":154,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":81},"100588786","phase-2-the-effect-of-oxytocin-nasal-spray-on-preventing-postoperative-delirium-in-elderly-patients-undergoing-orthopedic-surgery-100588786","NCT06945926","The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery","The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery：Two-Stage Designs for Phase II Clinical Trials","Elderly patients undergoing orthopedic surgery under general anesthesia\n\nInclusion criteria:\n\n1. Age ≥ 65 years;\n2. Patients who were to undergo elective orthopedic surgery under general anesthesia with tracheal intubation;\n3. ASA class I-III;\n4. Estimated duration of surgery ≥ 1 hour; (5) The patient himself\u002Fherself or his\u002Fher legal representative;\n5. Informed consent from the patient or legal representative;\n6. Proficiency in the use of Chinese language for communication.\n\nExclusion criteria:\n\n1. Nasal cavity occupation, patients with fillers in the nose\n2. Oxytocin allergy;\n3. Patients with previous psychiatric and neurological disorders, such as depression, severe central nervous system depression, Parkinson's disease, basal ganglia disease.\n\n   Goldson's disease, basal ganglia lesions, schizophrenia, epilepsy, Alzheimer's disease, myasthenia gravis, and so on;\n4. Pregnant and lactating women\n5. Patients with severe hepatic insufficiency (Child-Pugh class C);\n6. patients with severe renal insufficiency (dialysis is required before surgery)\n7. Severe heart failure (METS\\\u003C4);\n8. Preoperative inability to communicate (coma or dementia);\n9. Severe preoperative blindness, deafness, or inability to understand Mandarin to complete preoperative delirium screening;\n10. Preoperative cognitive impairment as determined by a MoCA evaluation prior to surgery;\n11. Patients who are scheduled for 2 surgeries within 7 days of surgery;\n12. Patients with bone malignancy\n13. Currently participating in other clinical trials.",{"count":143,"type":21},220,[145],"PHASE2","Postoperative delirium is a delirium that occurs within 7 days after surgery or before hospital discharge. It has been shown that combined POD can increase the incidence of postoperative pulmonary infections, deep vein thrombosis and decubitus ulcers, and increase the incidence of disability and mortality. The incidence of postoperative delirium in geriatric orthopedics is high.\n\nInvestigators conduct a prospective clinical study on geriatric orthopedic surgery patients to investigate the effect of oxytocin nasal spray on the prevention of postoperative delirium in geriatric orthopedic surgery. Cases were included according to the inclusion and exclusion criteria, and induction, maintenance and resuscitation were performed according to the standard protocol for general anesthesia. Before the end of surgery, the Investigators administered oxytocin nasal spray (Oxytocin) that was 3 sprays in each nostril (4 IU each) for a total of 24 IU. Beginning 1 day postoperatively, administer 24 IU of oxytocin nasal spray 2 times\u002Fday in the morning and in the evening. Until 7 days after surgery or discharge. The sample size are 77 cases in phase I and 143 cases in phase 2, total 220 cases.",[148,149,150,29,151,152,153],"Cervical Spinal Stenosis","Thoracic Spinal Stenosis","Lumbar Spinal Stenosis","Femoral Head Necrosis","Spinal Trauma","Knee Joint Injury",[155,156,157],"Postoperative delirium","elderly orthopedics","oxytocin nasal spray","2025-05-23",{"date":160,"type":41},"2025-05-25",{"date":162,"type":21},"2025-06-01",{"date":164,"type":21},"2026-06-30",{"name":166,"class":48},"Zhejiang University",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":4,"eligibilityCriteria":173,"healthyVolunteers":11,"sex":17,"minAge":110,"maxAge":56,"enrollmentInfo":174,"targetDuration":4,"studyType":22,"phases":176,"briefSummary":177,"conditions":178,"keywords":180,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":184,"lastUpdatePostDateStruct":185,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":81},"100587109","blood-flow-restriction-exercise-induced-hypoalgesia-100587109","NCT06924112","Blood Flow Restriction Exercise-induced Hypoalgesia","Exercise-induced Hypoalgesia Following Blood Flow Restriction in Rotator Cuff Repair Rehabilitation: a Randomized Crossover Clinical Trial","Inclusion Criteria:\n\n* Age between 40-65 years.\n* Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging.\n* Undergoing arthroscopic rotator cuff repair\n* Be able to read and understand Spanish.\n\nExclusion Criteria:\n\n* Massive irreparable RC tears, concomitant fracture, labral or nerve injury.\n* Suspicion of developing\u002Fdiagnosis a frozen shoulder.\n* Revision surgery after RC repair.\n* Previous corticosteroid injection (\\\u003C 1 year).\n* Recent surgery (\\\u003C 1 year) in the contralateral shoulder.\n* A history of deep venous thrombosis\u002Fpulmonary embolism.\n* Peripheral vascular disease, thrombophilia or clotting disorders.\n* Severe or uncontrolled hypertension, or any comorbid condition that prevents participants from complete the intervention.",{"count":175,"type":21},22,[24],"The goal of this crossover randomized clinical trial is to compare the acute effect on exercise-induced hypoalgesia (EIH) between isometric exercise with blood flow restriction (BFR) and isometric exercise alone in adults undergoing arthroscopic rotator cuff repair. It is presumed that the addition of BFR to isometric exercises induces a greater effect in EIH.\n\nPatients who agree to participate in this research will be randomly assigned to two intervention sequences (AB or BA), where intervention A (experimental) corresponds to isometric exercises with BFR, and intervention B (control) corresponds to isometric exercises alone. For one week, each participant attended two sessions, separated by a 72-hours wash-out period. The primary variables will be the pressure pain threshold (PPT) and conditioned pain modulation (CPM). Secondary variables will be the pain intensity and distribution, kinesiophobia, upper extremity disability, and quality of life. Results will be measured before intervention (T1, pre-intervention), immediate after intervention (T2, post-intervention 1) and 10 minutes after intervention (T3, post-intervention 2).",[29,116,179],"Rotator Cuff Repair",[181,182,183],"blood flow restriction therapy","blood flow restriction training","exercise-induced hypoalgesia","2025-04-04",{"date":186,"type":41},"2025-04-11",{"date":188,"type":21},"2025-05-01",{"date":190,"type":21},"2025-09-30",{"name":192,"class":48},"University of Valencia",{"id":194,"slug":195,"hasResults":11,"nctId":196,"briefTitle":197,"officialTitle":197,"acronym":198,"eligibilityCriteria":199,"healthyVolunteers":11,"sex":17,"minAge":110,"maxAge":4,"enrollmentInfo":200,"targetDuration":4,"studyType":22,"phases":201,"briefSummary":202,"conditions":203,"keywords":204,"overallStatus":124,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":215,"locationsCount":81},"100575633","self-locking-tenodesis-of-the-long-chief-of-the-biceps-vs-lasso-360-tenodesis-in-arthroscopic-rotator-cuff-repair-rotator-cuff-repair-100575633","NCT06774820","Self-locking Tenodesis of the Long Chief of the Biceps Vs. Lasso 360 Tenodesis in Arthroscopic Rotator Cuff Repair Rotator Cuff Repair","BLAST1","Inclusion Criteria:\n\n* Full-thickness rotator cuff tear of the supraspinatus\u002Finfraspinatus tendon, diagnosed preoperatively by ultrasound, arthro-CT or MRI.\n* Patients must be able to read and write in French in order to complete the questionnaires and sign the informed consent form.\n\nExclusion Criteria:\n\n* Partial rotator cuff tear\n* Massive and irreparable rotator cuff tear\n* Grade 4 according to Goutallier classification of fatty degeneration of rotator cuff muscles\n* Rupture of the long biceps\n* Hourglass deformity of biceps tendon origin\n* Osteoarthritis of the glenohumeral joint, defined by narrowing of the glenohumeral joint space or osteophytes, using AP radiography of the affected shoulder.\n* Distance between acromion and humeral head measuring 6 mm or less, defined by Hamada classification as grade 2 or higher.\n* Previous shoulder surgery.\n* Dementia or inability to complete questionnaires and assessments.\n* Pregnant, parturient or breast-feeding patients.\n* Persons under legal protection (curatorship, guardianship, safeguard of justice).\n* Persons deprived of their liberty by judicial or administrative measure\n* Persons under psychiatric care\n* Persons not affiliated to a social security scheme",{"count":20,"type":21},[24],"The aim of this study is to compare the clinical results and complications of self-locking biceps tenodesis and double 360 lasso loop biceps tenodesis for the treatment of long chief of biceps or superior labrum anterior-posterior (SLAP) tendon pathology during shoulder arthroscopy in patients undergoing arthroscopic rotator cuff repair. Currently, there is no consensus on the use of tenodesis versus tenotomy to treat pathology of the long head of the biceps during arthroscopic rotator cuff repair. Numerous studies have examined the clinical results of long biceps tenotomy versus long biceps tenodesis, and there is no evidence to date of superiority of either technique. At Clinique Générale, we use a new, innovative technique called autobloc tenodesis to treat pathologies of the long head of the biceps. There are no comparative studies between autobloc tenodesis of the biceps and biceps tenodesis. Given its potential advantages, self-locking biceps tenodesis could emerge as the new technique of choice for treating biceps longus tendon pathology, potentially reducing differences in outcomes such as Popeye deformity. The information provided by this study could potentially guide future clinical practice, helping surgeons to choose the most appropriate treatment for their patients suffering from long biceps tendon pathology.",[29],[205,206,207],"rotator cuff","biceps","long biceps tendon","2025-02-11",{"date":210,"type":41},"2025-02-12",{"date":212,"type":41},"2025-01-22",{"date":214,"type":21},"2028-01-15",{"name":216,"class":48},"Clinique Générale dAnnecy",{"id":218,"slug":219,"hasResults":11,"nctId":220,"briefTitle":221,"officialTitle":222,"acronym":223,"eligibilityCriteria":224,"healthyVolunteers":11,"sex":17,"minAge":110,"maxAge":56,"enrollmentInfo":225,"targetDuration":4,"studyType":22,"phases":226,"briefSummary":227,"conditions":228,"keywords":229,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":81},"100576671","blood-flow-restriction-versus-standard-exercise-after-rotator-cuff-repair-100576671","NCT06788327","Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair","Comparing the Effectiveness of Blood Flow Restriction Therapy Versus Standard Exercise After Arthroscopic Rotator Cuff Repair: Protocol for the Multicenter S-TRONGER Randomized Controlled Trial","S-TRONGER","Inclusion Criteria:\n\n* Age between 40-65 years\n* Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging\n* Undergoing arthroscopic rotator cuff repair\n* Be able to read and understand Spanish\n\nExclusion Criteria:\n\n* Massive irreparable rotator cuff tear\n* Concomitant fracture\n* Labral or nerve injury\n* Suspicious of developing a frozen shoulder\n* Revision surgery after rotator cuff repair\n* Previous corticosteroid injection (\\\u003C 6 months)\n* Recent surgery (\\\u003C 1 year) in the contralateral shoulder\n* History of deep venous thrombosis\u002Fpulmonary embolism, peripheral vascular disease, thrombophilia or clotting disorders\n* Severe or uncontrolled hypertension, or any comorbid condition that impedes participants to complete the intervention",{"count":112,"type":21},[24],"The goal of this clinical trial is to determine the effectiveness of postoperative standard exercises with blood flow restriction therapy (BFRT) versus standard exercises alone on shoulder muscle strength and mass in participants with surgically treated rotator cuff tear. It is presumed that the addition of BFRT will significantly improve the shoulder strength and muscle mass at the end of the intervention period compared to the group receiving only standard exercises.\n\nPatients who agree to participate in this research will be randomly assigned to a control group (standard exercises alone) or an experimental group (standard rehabilitation with BFRT). The duration of the postoperative intervention will be 12 weeks. The primary variables will be the shoulder muscle strength and muscle mass. Secondary variables will be the active shoulder mobility, pain intensity, upper limb disability, and health-related quality of life. Results will be measured at 0, 4 and 12 weeks postoperative.",[29,33,179],[181,182],"2025-01-16",{"date":232,"type":41},"2025-01-23",{"date":234,"type":21},"2025-03-03",{"date":236,"type":21},"2027-08-31",{"name":192,"class":48}]